Search details
1.
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients.
Antimicrob Agents Chemother
; 65(3)2021 02 17.
Article
in English
| MEDLINE | ID: mdl-33361296
2.
Pharmacokinetics of 2,000 Milligram Ertapenem in Tuberculosis Patients.
Antimicrob Agents Chemother
; 62(5)2018 05.
Article
in English
| MEDLINE | ID: mdl-29439978
3.
In Vitro Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin.
Antimicrob Agents Chemother
; 62(3)2018 03.
Article
in English
| MEDLINE | ID: mdl-29311078
4.
Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 61(4)2017 04.
Article
in English
| MEDLINE | ID: mdl-28137814
5.
Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 61(3)2017 03.
Article
in English
| MEDLINE | ID: mdl-28069654
6.
Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of Tuberculosis.
Antimicrob Agents Chemother
; 60(7): 3942-7, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27067336
7.
Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations.
Antimicrob Agents Chemother
; 60(5): 2727-31, 2016 05.
Article
in English
| MEDLINE | ID: mdl-26883707
8.
Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"
Antimicrob Agents Chemother
; 65(6)2021 05 18.
Article
in English
| MEDLINE | ID: mdl-33782002
9.
Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis.
Antimicrob Agents Chemother
; 57(8): 3676-80, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23689722
10.
Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I-Penicillins.
Clin Pharmacokinet
; 62(2): 221-247, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36662480
11.
The Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part III Non-penicillin and Non-cephalosporin Drugs.
Clin Pharmacokinet
; 62(3): 399-434, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36940039
12.
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience.
Eur Respir J
; 38(4): 888-94, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21310881
13.
Intravenous voriconazole after toxic oral administration.
Antimicrob Agents Chemother
; 54(6): 2741-2, 2010 Jun.
Article
in English
| MEDLINE | ID: mdl-20385853
14.
The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019.
Drugs
; 79(2): 161-171, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30617959
15.
Ethambutol-induced optical neuropathy: risk of overdosing in obese subjects.
Int J Tuberc Lung Dis
; 12(8): 967-71, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18647459
16.
A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products.
Eur J Pharm Sci
; 30(1): 15-20, 2007 Jan.
Article
in English
| MEDLINE | ID: mdl-17085024
17.
Population pharmacokinetics of infliximab in patients with inflammatory bowel disease: potential implications for dosing in clinical practice.
Aliment Pharmacol Ther
; 42(5): 529-39, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26113313
18.
Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis.
Int J Antimicrob Agents
; 46(3): 332-7, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26228464
19.
Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patients.
Int J Med Inform
; 83(8): 572-80, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24929633
20.
ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
J Control Release
; 172(3): 618-24, 2013 Dec 28.
Article
in English
| MEDLINE | ID: mdl-24096020